According to a new report published by K D Market Insights, titled, “Gene synthesis Market Insights, Trends, Opportunity Forecast, 2023–2032,” the global gene synthesis market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The increasing demand for synthetic genes in various applications, including pharmaceutical research, biotechnology, and agriculture. Gene synthesis plays a vital role in genetic engineering, drug discovery, and personalized medicine. Which are the major factors augmenting the growth of the global gene synthesis market.

The increasing demand for customized genetic material in various research and commercial applications propels the market. Gene synthesis allows researchers to design and produce genes with specific sequences and functions, enabling advancements in fields such as drug discovery, genetic engineering, and agricultural biotechnology are further expected to create ample growth opportunities for the global gene synthesis market during the forecast period i.e., 2023-2032. Moreover, the prevalence of chronic disorders is on the rise which has propelled market expansion., the growing adoption of gene synthesis in pharmaceutical research and development, is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global gene synthesis market in 2022. The region is further projected to continue dominating in the market and also register the highest CAGR in the market during the forecast period. This can be attributed to the presence of major pharmaceutical and biotechnology companies, robust research infrastructure, and government support for genetic research.

According to method, the solid-phase synthesis segment accounted for the largest market share in the gene synthesis market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

Request PDF Sample For More Information@ https://www.kdmarketinsights.com/sample/7370

The global gene synthesis market is segmented into method, services, applications, end users and region. Based on method, the market is bifurcated into solid-phase synthesis, chip- based synthesis, PCR- based enzyme synthesis, others. Based on services, it is classified into antibody DNA synthesis, viral DNA synthesis, others. Based on applications, it is classified into gene cell therapy development, vaccine development, diseases diagnosis, others. Based on, end users, it is classified into biotechnology pharmaceutical companies, academic government research institutes, contract research organizations.

The global gene synthesis market is analyzed across North America (U.S. Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East Africa).

Key Insights of Gene synthesis Market

• On the basis of method, the solid-phase synthesis segment accounted for the largest market share in the gene synthesis market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
• On the basis of region, North America accounted for the largest share in the global gene synthesis market in 2022. The region is further projected to continue dominating in the market during the forecast period.
• On the basis of region, Asia-Pacific is estimated to account for the second largest share in the market during the forecast period.

Some of the major gene synthesis companies profiled in the report includeGenScript, GENEWIZ, Boster Biological Technology, Twist Bioscience, ProteoGenix, Inc., Biomatik, ProMab Biotechnologies, Inc., Thermo Fisher Scientific, Inc., Integrated DNA Technologies, Inc., and OriGene Technologies, Inc.